Related Experiment Video
Updated: Jul 11, 2026
11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
MicroRNA expression signature of human sarcomas
S Subramanian1, W O Lui, C H Lee
1Department of Pathology, Stanford University, Stanford, CA 94305, USA.
Oncogene
|October 9, 2007
Summary
MicroRNA (miRNA) expression patterns differ across sarcoma types, aiding in diagnosis and potentially revealing tumorigenesis roles. This study identified unique miRNA signatures in various sarcomas, improving diagnostic accuracy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are small noncoding RNAs crucial for biological processes like development and differentiation.
- Altered miRNA expression is implicated in various cancers, suggesting potential diagnostic and therapeutic value.
Purpose of the Study:
- To comprehensively analyze miRNA expression profiles in different sarcoma subtypes.
- To identify unique miRNA signatures for each sarcoma class.
- To explore the diagnostic and tumorigenic roles of miRNAs in soft tissue sarcomas.
Main Methods:
- Microarray technology and small RNA cloning were used to profile miRNA expression in 27 sarcomas and normal muscle tissues.
- Unsupervised hierarchical clustering analyzed miRNA expression patterns.
- Histopathologic and molecular analyses confirmed diagnoses.
Main Results:
- Distinct miRNA expression profiles were observed among sarcoma types, enabling classification via hierarchical clustering.
- Unique miRNA signatures were identified for each sarcoma class.
- Analysis revealed two misdiagnosed sarcomas, confirmed by subsequent reevaluation.
- Thirty-one novel miRNAs or small RNA effectors were identified.
Conclusions:
- Different histological sarcoma types exhibit distinct miRNA expression patterns, correlating with lineage and differentiation.
- Unique miRNA signatures may play a role in sarcoma development and can aid in soft tissue sarcoma diagnosis.
Related Concept Videos
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...